Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kJ/mole | IC50 nM | Kd nM | EC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free fatty acid receptor 1 (Homo sapiens (Human)) | BDBM450607![]() ((2S,3R)-3-(2-(1-(2,5-bis(Trifluoromethyl)benzyl)pi...) | PDB Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | n/a | n/a | 611 | n/a | n/a | n/a | n/a |
Merch Sharp & Dohne Corp. Rahway US Patent | Assay Description The assay was performed in 384-well format. HEK cells stably expressing human GPR40 were plated at 7500 cells per well in growth medium (DMEM/10% fet... | US Patent US10676458 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Free fatty acid receptor 1 (Homo sapiens (Human)) | BDBM450622![]() (Sodium (2S,3R)-3-cyclopropyl-3-((R or S)-3-(2̸...) | PDB Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | n/a | n/a | 0.800 | n/a | n/a | n/a | n/a |
Merch Sharp & Dohne Corp. Rahway US Patent | Assay Description The assay was performed in 384-well format. HEK cells stably expressing human GPR40 were plated at 7500 cells per well in growth medium (DMEM/10% fet... | US Patent US10676458 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Free fatty acid receptor 1 (Homo sapiens (Human)) | BDBM450616![]() (Sodium (2S,3R)-3-cyclopropyl-3-((R or S)-2-(2̸...) | PDB Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | n/a | n/a | 0.200 | n/a | n/a | n/a | n/a |
Merch Sharp & Dohne Corp. Rahway US Patent | Assay Description The assay was performed in 384-well format. HEK cells stably expressing human GPR40 were plated at 7500 cells per well in growth medium (DMEM/10% fet... | US Patent US10676458 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Free fatty acid receptor 1 (Homo sapiens (Human)) | BDBM450608![]() (Sodium (2S,3S)-3-((R or S)-3-(1-(2,5-Bis(trifluoro...) | PDB Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | n/a | n/a | 388 | n/a | n/a | n/a | n/a |
Merch Sharp & Dohne Corp. Rahway US Patent | Assay Description The assay was performed in 384-well format. HEK cells stably expressing human GPR40 were plated at 7500 cells per well in growth medium (DMEM/10% fet... | US Patent US10676458 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Free fatty acid receptor 1 (Homo sapiens (Human)) | BDBM450610![]() (Sodium (2S,3S)-3-((R or S)-3-(1-(2,5-bis(trifluoro...) | PDB Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | n/a | n/a | 4.70E+3 | n/a | n/a | n/a | n/a |
Merch Sharp & Dohne Corp. Rahway US Patent | Assay Description The assay was performed in 384-well format. HEK cells stably expressing human GPR40 were plated at 7500 cells per well in growth medium (DMEM/10% fet... | US Patent US10676458 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Free fatty acid receptor 1 (Homo sapiens (Human)) | BDBM450612![]() (Sodium (2S,3R)-3-((R or S)-2-(1-(2,5-bis(trifluoro...) | PDB Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | n/a | n/a | 99 | n/a | n/a | n/a | n/a |
Merch Sharp & Dohne Corp. Rahway US Patent | Assay Description The assay was performed in 384-well format. HEK cells stably expressing human GPR40 were plated at 7500 cells per well in growth medium (DMEM/10% fet... | US Patent US10676458 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Free fatty acid receptor 1 (Homo sapiens (Human)) | BDBM450618![]() ((2S,3R)-3-cyclopropyl-3-((R or S)-2-(2′-fluo...) | PDB Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | n/a | n/a | 12 | n/a | n/a | n/a | n/a |
Merch Sharp & Dohne Corp. Rahway US Patent | Assay Description The assay was performed in 384-well format. HEK cells stably expressing human GPR40 were plated at 7500 cells per well in growth medium (DMEM/10% fet... | US Patent US10676458 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Free fatty acid receptor 1 (Homo sapiens (Human)) | BDBM450616![]() (Sodium (2S,3R)-3-cyclopropyl-3-((R or S)-2-(2̸...) | PDB Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | n/a | n/a | 0.790 | n/a | n/a | n/a | n/a |
Merch Sharp & Dohne Corp. Rahway US Patent | Assay Description The assay was performed in 384-well format. HEK cells stably expressing human GPR40 were plated at 7500 cells per well in growth medium (DMEM/10% fet... | US Patent US10676458 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Free fatty acid receptor 1 (Homo sapiens (Human)) | BDBM450618![]() ((2S,3R)-3-cyclopropyl-3-((R or S)-2-(2′-fluo...) | PDB Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | n/a | n/a | 1 | n/a | n/a | n/a | n/a |
Merch Sharp & Dohne Corp. Rahway US Patent | Assay Description The assay was performed in 384-well format. HEK cells stably expressing human GPR40 were plated at 7500 cells per well in growth medium (DMEM/10% fet... | US Patent US10676458 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Free fatty acid receptor 1 (Homo sapiens (Human)) | BDBM450620![]() (Sodium (2S,3R)-3-cyclopropyl-3-((R or S)-3-(2̸...) | PDB Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | n/a | n/a | 0.800 | n/a | n/a | n/a | n/a |
Merch Sharp & Dohne Corp. Rahway US Patent | Assay Description The assay was performed in 384-well format. HEK cells stably expressing human GPR40 were plated at 7500 cells per well in growth medium (DMEM/10% fet... | US Patent US10676458 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Free fatty acid receptor 1 (Homo sapiens (Human)) | BDBM450615![]() ((2S,3R)-3-((S or R)-2-(1- (2,5-bis(trifluoromethyl...) | PDB Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | n/a | n/a | 289 | n/a | n/a | n/a | n/a |
Merch Sharp & Dohne Corp. Rahway US Patent | Assay Description The assay was performed in 384-well format. HEK cells stably expressing human GPR40 were plated at 7500 cells per well in growth medium (DMEM/10% fet... | US Patent US10676458 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Free fatty acid receptor 1 (Homo sapiens (Human)) | BDBM450620![]() (Sodium (2S,3R)-3-cyclopropyl-3-((R or S)-3-(2̸...) | PDB Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | n/a | n/a | 10 | n/a | n/a | n/a | n/a |
Merch Sharp & Dohne Corp. Rahway US Patent | Assay Description The assay was performed in 384-well format. HEK cells stably expressing human GPR40 were plated at 7500 cells per well in growth medium (DMEM/10% fet... | US Patent US10676458 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Free fatty acid receptor 1 (Homo sapiens (Human)) | BDBM450610![]() (Sodium (2S,3S)-3-((R or S)-3-(1-(2,5-bis(trifluoro...) | PDB Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | n/a | n/a | 2.10E+3 | n/a | n/a | n/a | n/a |
Merch Sharp & Dohne Corp. Rahway US Patent | Assay Description The assay was performed in 384-well format. HEK cells stably expressing human GPR40 were plated at 7500 cells per well in growth medium (DMEM/10% fet... | US Patent US10676458 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Free fatty acid receptor 1 (Homo sapiens (Human)) | BDBM450612![]() (Sodium (2S,3R)-3-((R or S)-2-(1-(2,5-bis(trifluoro...) | PDB Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | n/a | n/a | 35 | n/a | n/a | n/a | n/a |
Merch Sharp & Dohne Corp. Rahway US Patent | Assay Description The assay was performed in 384-well format. HEK cells stably expressing human GPR40 were plated at 7500 cells per well in growth medium (DMEM/10% fet... | US Patent US10676458 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Free fatty acid receptor 1 (Homo sapiens (Human)) | BDBM450622![]() (Sodium (2S,3R)-3-cyclopropyl-3-((R or S)-3-(2̸...) | PDB Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | n/a | n/a | 12 | n/a | n/a | n/a | n/a |
Merch Sharp & Dohne Corp. Rahway US Patent | Assay Description The assay was performed in 384-well format. HEK cells stably expressing human GPR40 were plated at 7500 cells per well in growth medium (DMEM/10% fet... | US Patent US10676458 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Free fatty acid receptor 1 (Homo sapiens (Human)) | BDBM450609![]() (Sodium (2S,3R)-methyl 3- ((S or R)-3-(1-(2,5- bis(...) | PDB Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | n/a | n/a | 642 | n/a | n/a | n/a | n/a |
Merch Sharp & Dohne Corp. Rahway US Patent | Assay Description The assay was performed in 384-well format. HEK cells stably expressing human GPR40 were plated at 7500 cells per well in growth medium (DMEM/10% fet... | US Patent US10676458 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Free fatty acid receptor 1 (Homo sapiens (Human)) | BDBM450614![]() ((2S,3R)-3-((R or S)-2-(1-(2,5-bis(trifluoromethyl)...) | PDB Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | n/a | n/a | 439 | n/a | n/a | n/a | n/a |
Merch Sharp & Dohne Corp. Rahway US Patent | Assay Description The assay was performed in 384-well format. HEK cells stably expressing human GPR40 were plated at 7500 cells per well in growth medium (DMEM/10% fet... | US Patent US10676458 (2020) | |||||||||||
More data for this Ligand-Target Pair |